These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1436338)

  • 1. Neurotoxicity associated with oral acyclovir in patients undergoing dialysis.
    MacDiarmaid-Gordon AR; O'Connor M; Beaman M; Ackrill P
    Nephron; 1992; 62(3):280-3. PubMed ID: 1436338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity associated with acyclovir in end stage renal failure.
    Kitching AR; Fagg D; Hay NM; Hatfield PJ; Macdonald A
    N Z Med J; 1997 May; 110(1043):167-9. PubMed ID: 9196501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity of acyclovir in patients with end-stage renal failure treated with continuous ambulatory peritoneal dialysis.
    Davenport A; Goel S; Mackenzie JC
    Am J Kidney Dis; 1992 Dec; 20(6):647-9. PubMed ID: 1462997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes zoster associated encephalitis in dialysis patients.
    Cheung WC; Yuen KY; Chang CM; Cheng KP
    J Infect; 1991 Sep; 23(2):169-74. PubMed ID: 1753116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxicity induced by the recommended acyclovir dosing in a dialysis patient with herpes zoster: A case letter.
    Kageyama R; Hashizume H
    J Dermatol; 2016 Mar; 43(3):339-40. PubMed ID: 26589129
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of valaciclovir dosage reduction in continuous ambulatory peritoneal dialysis patients.
    Stathoulopoulou F; Dhillon S; Thodis H; Stathakis C; Vargemezis V
    Nephron; 2002 May; 91(1):164-6. PubMed ID: 12021536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Severe central nervous system symptoms following oral administration of acyclovir in a patient with chronic renal failure: a case report].
    Niibori D; Fujisawa M; Matsuzaki M
    Hinyokika Kiyo; 1993 May; 39(5):459-61. PubMed ID: 8322628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acyclovir encephalopathy in a peritoneal dialysis patient despite adjusting the dose of oral acyclovir: a case report].
    Kawabe Matsukawa M; Suzuki Y; Ikuma D; Suwabe T; Uesaka Y; Sugimoto I
    Rinsho Shinkeigaku; 2019 Dec; 59(12):834-839. PubMed ID: 31761838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoiding acyclovir neurotoxicity in patients with chronic renal failure undergoing haemodialysis.
    Almond MK; Fan S; Dhillon S; Pollock AM; Raftery MJ
    Nephron; 1995; 69(4):428-32. PubMed ID: 7777108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More about acyclovir neurotoxicity in patients on haemodialysis.
    Gómez Campderá FJ; Verde E; Vozmediano MC; Valderrábano F
    Nephron; 1998; 78(2):228-9. PubMed ID: 9496746
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensification of peritoneal dialysis improves valacyclovir neurotoxicity.
    Pipili C; Pantelias K; Deda E; Tsiamalos P; Kostis E; Grapsa E
    Ren Fail; 2013; 35(2):289-90. PubMed ID: 23176110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclovir neurotoxicity: clinical experience and review of the literature.
    Adair JC; Gold M; Bond RE
    South Med J; 1994 Dec; 87(12):1227-31. PubMed ID: 7973922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella zoster virus reactivation in hemodialysis patients: manifestations, treatment, complications and outcome.
    Mesar I; Basić-Jukić N; Hudolin T; Katalinić L; Kes P
    Acta Clin Croat; 2011 Dec; 50(4):549-52. PubMed ID: 22649885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valacyclovir neurotoxicity in a patient with end-stage renal disease treated with continuous ambulatory peritoneal dialysis.
    Okada T; Nakao T; Matsumoto H; Nagaoka Y; Iwasawa H; Nanri K; Yamazaki T
    Clin Nephrol; 2002 Aug; 58(2):168-70. PubMed ID: 12227692
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropsychiatric toxicity in a patient undergoing hemodialysis and receiving treatment with oral acyclovir.
    Collins A; Krieff D; Smith C; Singer C
    Clin Infect Dis; 1996 Jan; 22(1):187-8. PubMed ID: 8825003
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute renal failure and coma after a high dose of oral acyclovir.
    Eck P; Silver SM; Clark EC
    N Engl J Med; 1991 Oct; 325(16):1178-9. PubMed ID: 1891032
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraperitoneal administration of acyclovir in patients receiving continuous ambulatory peritoneal dialysis.
    Burgess ED; Gill MJ
    J Clin Pharmacol; 1990 Nov; 30(11):997-1000. PubMed ID: 2243158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure induced by oral acyclovir.
    Hernandez E; Praga M; Moreno F; Montoyo C
    Clin Nephrol; 1991 Sep; 36(3):155-6. PubMed ID: 1934676
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacokinetics of oral acyclovir in patients on continuous ambulatory peritoneal dialysis.
    Stathoulopoulou F; Almond MK; Dhillon S; Raftery MJ
    Nephron; 1996; 74(2):337-41. PubMed ID: 8893152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclovir-associated encephalopathy in haemodialysis.
    Peces R; de la Torre M; Alcázar R
    Nephrol Dial Transplant; 1996 Apr; 11(4):752. PubMed ID: 8671884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.